Who owns IMMUNOPRECISE ANTIBODIES LTD COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Immunoprecise Antibodies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Immunoprecise Antibodies stock

Who bought or sold IMMUNOPRECISE ANTIBODIES LTD COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Ingalls & Snyder 1.3M $2.2M 25% Dec 2023
 View chart
Citadel Advisors 302k $517k 25% Dec 2023
 View chart
Squarepoint Ops 48k $82k 100% Dec 2023
 View chart
Bank Of Montreal 48k $83k -74% Dec 2023
 View chart
Gradient Capital Advisors 27k $41k 0% Mar 2024
 View chart
Millennium Management 19k $33k 100% Dec 2023
 View chart
Dimensional Fund Advisors 12k $21k -23% Dec 2023
 View chart
UBS Group 11k $18k 15157% Dec 2023
 View chart
Mariner Wealth Advisors 10k $17k 100% Dec 2023
 View chart
Royal Bank of Canada 3.1k $5.0k 0% Dec 2023
 View chart
Simplex Trading 2.7k $4.0k 23% Dec 2023
 View chart
West Paces Advisors 1.7k $2.5k 0% Mar 2024
 View chart
National Bank Of Canada /fi/ 1.5k $2.5k 0% Dec 2023
 View chart
TD Waterhouse Canada 200.00 $420.000000 0% Dec 2023
 View chart
Citigroup 7.00 $12.000100 0% Dec 2023
 View chart

Who sold out of Immunoprecise Antibodies?

Fund or Company Name Date Sold Shares Held Valued At
Cutler Dec 2023 60.00 $0